Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Current Biomedicine
Maula, Yogi Nikmatul
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health Veterinary

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Comparative superovulation outcomes across estrous phases using PMSG-hCG and rFSH-rhCG in mice Maula, Yogi Nikmatul; Salsabila, Cyntia Bella; Pristihadi, Diah Nugrahani; Haq, Noer Muhammad Dliyaul; Boediono, Arief
Current Biomedicine Vol. 3 No. 2 (2025): July
Publisher : School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29244/currbiomed.3.2.86

Abstract

Background Enhancing stimulation efficiency in mice supports the application of assisted reproductive technologies (ART) for species conservation. Objective This study compared the stimulatory potential of two ART-supporting hormone protocols: the conventional PMSG-hCG combination and recombinant gonadotropins (rFSH-rhCG), a newer generation produced by genetic engineering. Methods Sixty-three female mice from four distinct estrous phases were used in this study. Both hormone regimens, with FSH- and LH-like activities, were administered sequentially between 4:00 and 5:00 pm, at a 47–48 h interval. Stimulation success was evaluated based on the proportion of females showing a positive response and the number of oocytes retrieved. Results The diestrus phase yielded the highest response for both treatments. Approximately 60% of the females responded to PMSG-hCG, and 80% responded to recombinant hormones. The number of oocytes recovered reached 239 in the PMSG-hCG group and 137 in the recombinant group. Interestingly, recombinant hormone administration during estrus induced ovulation of 400 oocytes; however, the efficiency ratio was lower than that during diestrus (30.8 vs 34.3). Conclusion Both PMSG-hCG and recombinant gonadotropins effectively stimulate ovulation. The diestrus phase provides the most consistent results; therefore, diestrus is recommended as the optimal stage for superovulation protocols in mice.
Co-Authors Arief Boediono Diah Nugrahani Pristihadi Noer Muhammad Dliyaul Haq, Noer Muhammad Dliyaul Salsabila, Cyntia Bella